Filter your results
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: Multicenter study from the french uveitis networkArthritis & rheumatology, 2016, 66 (6), pp.1522-1530. ⟨10.1002/art.39667⟩
Journal articles
hal-01301142v1
|